Chemoinformaics analysis of 3-Methoxycinnamaldehyde
Molecular Weight | 162.188 | nRot | 3 |
Heavy Atom Molecular Weight | 152.108 | nRig | 8 |
Exact Molecular Weight | 162.068 | nRing | 1 |
Solubility: LogS | -2.584 | nHRing | 0 |
Solubility: LogP | 1.872 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 24.9719 |
nHD | 0 | BPOL | 12.6361 |
QED | 0.501 |
Synth | 2.023 |
Natural Product Likeliness | 0.468 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.014 |
CACO-2 | -4.519 |
MDCK | 0.0000149 |
BBB | 0.99 |
PPB | 0.833622 |
VDSS | 1.271 |
FU | 0.137934 |
CYP1A2-inh | 0.979 |
CYP1A2-sub | 0.831 |
CYP2c19-inh | 0.549 |
CYP2c19-sub | 0.486 |
CYP2c9-inh | 0.07 |
CYP2c9-sub | 0.929 |
CYP2d6-inh | 0.142 |
CYP2d6-sub | 0.903 |
CYP3a4-inh | 0.093 |
CYP3a4-sub | 0.216 |
CL | 6.937 |
T12 | 0.653 |
hERG | 0.077 |
Ames | 0.647 |
ROA | 0.026 |
SkinSen | 0.942 |
Carcinogencity | 0.871 |
EI | 0.993 |
Respiratory | 0.847 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.881079 |